A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-center study, investigating the efficacy and safety of
terlipressin in Japanese patients with hepatorenal syndrome type 1.